about
Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individualsClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionReview article: the assessment and management of chronic severe gastrointestinal dysmotility in adultsThe role of naloxegol in the management of opioid-induced bowel dysfunctionOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenOpioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategiesVgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.Prevalence of opioid dispensings and concurrent gastrointestinal medications in QuebecMethylnaltrexone: the evidence for its use in the management of opioid-induced constipation.Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationLubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.Neurochemical phenotype and function of endomorphin 2-immunopositive neurons in the myenteric plexus of the rat colon.Opioid receptors in the gastrointestinal tract.Divergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats.Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.New approaches to the treatment of opioid-induced constipation.Lubiprostone for the treatment of opioid-induced bowel dysfunction.Validated tools for evaluating opioid-induced bowel dysfunction.Opioid-induced bowel dysfunction: pathophysiology and management.The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilitiesOpioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.The Effect of DA-9701 in Opioid-induced Bowel Dysfunction of Guinea Pig.Opioid-induced bowel dysfunction.Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database.The effect of opioid agonists and antagonists on gastrointestinal motility in mice selected for high and low swim stress-induced analgesia.A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.The gut-brain interaction in opioid tolerance.Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl.Investigational opioid antagonists for treating opioid-induced bowel dysfunction.[Bilateral hydronephrosis as a result of opioid-induced bowel spasm in a patient with an ileal conduit].European Perspectives on Pain And Palliative Care
P2860
Q26745747-B9DD7F60-E759-4503-92F8-0CF32A47C393Q26995944-F9B616D5-9958-45D2-8400-68A72C3934B9Q27010907-9A9601A9-98C2-4263-9045-431D5619B15BQ27030666-C90B93FD-C42D-4972-8B23-D942D195786CQ28072039-A1DD4AF8-ABE2-45F7-B6EA-45319B03CC73Q28209970-8F49F5E6-A0B3-4230-A832-7C11847FA8FCQ28294194-8E2FEE0B-8B91-4677-9CA7-214E896894A9Q33296232-BB353691-986A-4AF6-BF85-A355460DA46FQ33562118-98F78EE2-757F-4A87-A73F-D602D82AB074Q33973870-3E34331D-C3CC-4F4F-A959-D50E450F9885Q34146166-5FB2BA4C-5C72-4F82-BCA0-98AEB1176C0FQ34552212-AA79D543-2D82-401F-A63C-27B39CF59C18Q34708533-C54EBD77-3771-4625-9000-4457158213C1Q35185222-DA391242-2454-450D-B634-502D4099452EQ36274984-03016FCA-5200-4009-B245-3A6550AD3090Q36480105-2518CAD7-3ACE-4575-90D1-1089C13C198EQ37299608-5906E3FC-C661-4574-BF1A-D2D307AF9711Q37850804-32259CED-F67F-4E2B-9022-D4C017C61DF9Q37857765-C26A0398-AE4E-451A-A4C8-A4381A214267Q38040843-4928F399-9C76-480A-A203-23923BB618BFQ38116004-5EE5F4E0-58BA-44EA-B1E3-ABC914952C4BQ38248065-6C36D1B0-A338-4C3D-8816-59942C127BE4Q39051851-3CDC414B-6188-4C4F-9108-AF0CE0CF5354Q41977439-2B278E1A-0444-4C0C-971B-1837BD7BA74BQ42323281-4FD1BC0D-1ECF-4CF7-8B85-6D877101EA97Q43062741-F5E4054A-FEF0-405C-B5B3-0C3AED98C982Q43512843-C800DA39-EDC6-40D1-860C-16379479DF55Q44333143-38FEDF43-B267-4B7B-89CE-4A2E060974E2Q44339976-16D9763A-26FE-4D62-AF15-153E0DEAF9E4Q44351000-EEBB6EB6-9A6C-42FF-B438-E73FC01D1DC6Q48209130-7B16D2DF-9B1D-4821-94C3-F34F5CB2D9C6Q52740718-EEDE3CE7-38DC-4166-90FD-CD83073D6102Q53612053-B0497575-FFB9-4644-B525-7CD7E0D16BB5Q57878978-6DD54178-E0B1-4799-83B1-072ECE8F950D
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Treatment of opioid-induced gut dysfunction
@ast
Treatment of opioid-induced gut dysfunction
@en
Treatment of opioid-induced gut dysfunction
@nl
type
label
Treatment of opioid-induced gut dysfunction
@ast
Treatment of opioid-induced gut dysfunction
@en
Treatment of opioid-induced gut dysfunction
@nl
prefLabel
Treatment of opioid-induced gut dysfunction
@ast
Treatment of opioid-induced gut dysfunction
@en
Treatment of opioid-induced gut dysfunction
@nl
P2860
P3181
P1476
Treatment of opioid-induced gut dysfunction
@en
P2093
Peter Holzer
P2860
P304
P3181
P356
10.1517/13543784.16.2.181
P407
P577
2007-02-01T00:00:00Z